» Articles » PMID: 10917558

Incidence and Survival for Cancer in Children and Young Adults in the North of England, 1968-1995: a Report from the Northern Region Young Persons' Malignant Disease Registry

Overview
Journal Br J Cancer
Specialty Oncology
Date 2000 Aug 6
PMID 10917558
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The Northern Region Young Persons' Malignant Disease Registry records information on young people under 25 years old diagnosed with cancer in the Northern Region of England. Incidence and survival rates were calculated for children and young adults diagnosed with cancer between 1968 and 1995. There were 2099 (M:F 1.28:1) children (age 0-14 years) and 2217 (M:F 1.23:1) young adults (15-24 years) diagnosed with a first cancer between 1968 and 1995. The age-standardized rate (ASR) for childhood cancer was 121 per million 0 to 14 year-olds per year. For young adults the ASR was 175 per million 15 to 24 year-olds, per year. Incidence of childhood cancer increased over time at a rate of 12 extra cases per million children, per decade (P < 0.001). In young adults incidence rates increased by 16 extra cases per million 15 to 24 year-olds, per decade (P < 0.001). For childhood cancer 5-year survival was 42% for those diagnosed 1968-1977, 57% for 1978-1987 and 71% (95% CI 67-75) for 1988-1995. Survival for young adults over the three periods was 45%, 62% and 73% (95% CI 70-78) respectively. The cumulative risk of developing cancer before the age of 25 is 1 in 285. Over the 28-year period there were significant improvements in survival and modest increases in incidence in both children and young adults.

Citing Articles

Pharmacophore-Model-Based Virtual-Screening Approaches Identified Novel Natural Molecular Candidates for Treating Human Neuroblastoma.

Dain Md Opo F, Alkarim S, Alrefaei G, Molla M, Alsubhi N, Alzahrani F Curr Issues Mol Biol. 2022; 44(10):4838-4858.

PMID: 36286044 PMC: 9600652. DOI: 10.3390/cimb44100329.


Temporal clustering of neuroblastic tumours in children and young adults from Ontario, Canada.

Hayes L, Basta N, Muirhead C, Pole J, Gibson P, Di Monte B Environ Health. 2022; 21(1):30.

PMID: 35255910 PMC: 8902763. DOI: 10.1186/s12940-022-00846-y.


Intracranial Metastases Tend to Be Overt and Predict Poor Prognosis in Children With Neuroblastoma.

Huo L, Zhang J, Liu Y Front Pediatr. 2021; 9:716880.

PMID: 34805033 PMC: 8596640. DOI: 10.3389/fped.2021.716880.


Secondary brain metastases of Ewing's sarcoma presenting with collapse after 6 years of complete remission.

Poh J Clin Case Rep. 2021; 9(1):560-565.

PMID: 33489215 PMC: 7813011. DOI: 10.1002/ccr3.3583.


Clinical Features and Prognostic Factors in Elderly Ewing Sarcoma Patients.

Liu H, Wang J, Zhang D, Lan S, Chen Q Med Sci Monit. 2018; 24:9370-9375.

PMID: 30580374 PMC: 6320658. DOI: 10.12659/MSM.911882.


References
1.
Elder D . Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer. 1995; 75(1 Suppl):245-56. DOI: 10.1002/1097-0142(19950101)75:1+<245::aid-cncr2820751310>3.0.co;2-7. View

2.
Dorfman H, Czerniak B . Bone cancers. Cancer. 1995; 75(1 Suppl):203-10. DOI: 10.1002/1097-0142(19950101)75:1+<203::aid-cncr2820751308>3.0.co;2-v. View

3.
Kinlen L . Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer. 1995; 71(1):1-5. PMC: 2033475. DOI: 10.1038/bjc.1995.1. View

4.
Stiller C . Population based survival rates for childhood cancer in Britain, 1980-91. BMJ. 1994; 309(6969):1612-6. PMC: 2541972. DOI: 10.1136/bmj.309.6969.1612. View

5.
Fritschi L, Coates M, McCredie M . Incidence of cancer among New South Wales adolescents: which classification scheme describes adolescent cancers better?. Int J Cancer. 1995; 60(3):355-60. DOI: 10.1002/ijc.2910600314. View